Examining industry challenges with Tim Morant, Chief Risk Assessment Officer

An update on the success of our two-year partnership with GRAIL to promote early cancer detection in the US life insurance industry.

Sean Kim, Head of M&A Solutions, discusses the pivotal role reinsurance in the life and annuity mergers and acquisitions (M&A) market.

Combination products providing both long-term care and life insurance coverage are a market opportunity for carriers.

Claims professionals are well-positioned to provide insights and guidance tonavigate rapid change.

Our underwriting case clinic series exploring challenging medical conditions.

Our underwriting case clinic series exploring challenging medical conditions.

Our underwriting case clinic series exploring challenging medical conditions.

Our underwriting case clinic series exploring challenging medical conditions.

Our underwriting case clinic series exploring challenging medical conditions.

Munich Re’s Dr. Tim Meagher assesses studies on post-COVID-19 autoimmune disorders and their relevance to life insurance.

Dr. Tim Meagher reviews the evidence regarding increased morbidity and mortality risks for those with long-term COVID-19 infection and its relevance for insured populations

Dr. Tim Meagher examines the increase in both type 1 and type 2 diabetes that has occurred during the pandemic.

Claims professionals are well-positioned to provide insights and guidance tonavigate rapid change.

Dr. Tim Meagher provides an update on long Covid, with a particular focus on disease prevalence, disability, and risk factors.

In this series, we examine medical innovations impacting life and disability insurance, including advancements in HIV treatment.

Insurance updates and insights into HIV infection

An in-depth exploration of clinical lab histories

In this white paper series, we examine the opioid epidemic and its significance for the life insurance industry.

Munich Re’s Dr. Tim Meagher assesses studies on post-COVID-19 autoimmune disorders and their relevance to life insurance.

Dr. Tim Meagher reviews the evidence regarding increased morbidity and mortality risks for those with long-term COVID-19 infection and its relevance for insured populations

Dr. Tim Meagher discusses the recent reclassification of pituitary adenomas as ‘pituitary neuroendocrine tumors'.

Dr. Tim Meagher explores the potential impact of generative AI on the medical profession.

Dr. Tim Meagher explores the potential impact of medical nomenclature changes.

With the rise of marijuana use, underwriters must understand the latest research and take a balanced approach to risk assessment.

We assess the implications on insuring this industry for employee benefits.

We performed a sensitivity analysis to estimate the mortality impact of extreme what-if marijuana-use scenarios.

Substance abuse mortality is rising, with synthetic opioids fueling alarming trends. Discover what this means for life insurers and underwriting strategies.

We surveyed 18 leading group term life carriers to understand how opioid mortality affects claims.

Is it financially feasible to screen all life applicants for opioid use?

In this white paper series, we examine the opioid epidemic and its significance for the life insurance industry.

How did we get here?

A person commits suicide every 11.9 minutes. What toll does that take, emotionally and economically?

Best practices for practicioners

The 2017 clinical analysis of general and insured population suicides in the US

Analysis of General and Insured Population Suicides in the U.S.

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

A follow-up article that dives into the most common reasons for misclassification

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

Mortality slippage trends in accelerated underwriting and best practices for random holdout and post-issue audit monitoring.

alitheia integrates ExamOne LabPiQture as a data source to assess lab values and provide nuanced handling for more accurate automated decisioning

alitheia's team discusses assigning a medical severity to free-text application entries to use in automated decisioning.

A webinar on how insurers and reinsurers are reinventing underwriting processes to adapt to a new era of data and digitization.

How they work together

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

An update on the rapidly evolving adoption of electronic heath records (EHRs) in life insurance underwriting from the experts at Munich Re and Clareto.

Discover how Munich Re is making them easier to access and integrate.

How does this predictive modeling tool assess mortality risk?

How does this predictive modeling tool assess mortality risk?

Stratifying mortality risk by combining behavioral attributes and medical data.

An in-depth exploration of clinical lab histories

How does this predictive modeling tool assess mortality risk?

Munich Re's experts explore how income validations shed light on disability claims

Obesity

Prevention

Could uncertainty be taken out of underwriting and pricing in the Group Benefits market through technology-enabled risk evaluation?

Multiple studies have shown that regular physical activity, including walking, decreases the risk or severity of many health issues.

How novel data from wearables (activity, sleep, heart rate) helps life insurance underwriting and wellness initiatives.

A review of how mobile apps are used, in conjunction with medications, as a self-management tool for managing epilepsy.

Stratifying mortality risk using physical activity as measured by wearable sensors

A way for life insurance companies to change the way we interact with our customers and improve how we manage risk?

What is the impact on employee benefits?

Musculoskeletal disease and injury is a risk we all face – and it’s on the rise

Creating a competitive edge

Technological advancements and the evolution of disability risk as it relates to occupational changes

A closer look at LLM accuracy, the developing regulatory landscape, and expected implementation costs. 

Dr. Tim Meagher explores the potential impact of generative AI on the medical profession.

Large language models could unlock difficult-to-access data and insights for underwriting and claims.

Can large language models help unlock unstructed data trapped in documents such as attending physician statements?

Creating a robust AI strategy for AI in insurance

EHRs 2.0: A new era of data-driven underwriting

Electronic Health Records podcast series

Electronic Health Records podcast series

Electronic Health Records podcast series

Munich Re analysis of UK Biobank data shows value in novel variables not typically used in life insurance underwriting.

Munich Re analysis of UK Biobank data shows value in novel variables not typically used in life insurance underwriting.

Obesity

How novel data from wearables (activity, sleep, heart rate) helps life insurance underwriting and wellness initiatives.

The first of four white papers sharing Munich Re insights from our study on wearable data use in accelerated underwriting.